Drug Profile
Y-ART-3
Alternative Names: Sulfated pentagalloyl glucoseLatest Information Update: 10 Sep 1998
Price :
$50
*
At a glance
- Originator Yamanouchi
- Class Antivirals
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 10 Sep 1998 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 25 Jun 1996 New profile
- 25 Jun 1996 Preclinical development for HIV infections treatment in Japan (Unknown route)